MarginsXMarginsX
Home › Markets › Health Care › BLLN

BillionToOne Inc. (BLLN)

BLLN trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$96.31
-8.41% on the day
Market cap
$4.6B
Mid cap
Revenue · 2025
$305.1M
+100.0% on 2024
Net income · 2025
$7.5M
2.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/2070849/000207084926000017/0002070849-26-000017-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBLLN on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2025
SEC CIK0002070849
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$305.1M
Net income$7.5M
Operating income$16.0M
Net margin2.4%
Operating margin5.3%
Revenue growth+100.0%
Cash$496.0M
Total assets$632.7M
P/E (computed)617.3×
P/S (computed)15.1×

Warning signs

Cash runway
Cash-flow positive
$561.5M cash at September 30, 2026
Share count, 1 year
+4.4%
2025-11-30 to 2026-11-02
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$39.7M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$561.5M cash; operating cash flow $12.0M a quarter.Report 2026-09-30
Shares outstanding47,774,848 (2026-11-02); 45,768,760 a year earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Florham Park, New Jersey, United StatesPCAOB Form AP 2026-03-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $3.2M, sold $42.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$123.0M$17.4M$12.5M$561.5M$89.0M$436.9M10-Q 2026-11-04
Q2 2026
2026-06-30
$109.4M$8.1M$9.1M$548.6M$91.0M$397.4M10-Q 2026-08-05
Q1 2026
2026-03-31
$108.4M$18.0M$15.4M$537.5M$90.0M$354.5M10-Q 2026-05-06
Q4 2025
2025-12-31
$96.1M$6.0M$10.8M$496.0M$57.2M$305.1M10-K 2026-03-11
Q3 2025
2025-09-30
$83.5M$5.7M$10.0M$195.2M$55.0M$254.1M10-Q 2026-11-04
Q2 2025
2025-06-30
$66.6M-$246K$1.2M$189.0MNo debt tags$209.0M10-Q 2026-08-05
Q1 2025
2025-03-31
$59.0M-$4.0M$2.6M$191.6MNo debt tagsNeeds four quarters10-Q 2026-05-06
Q4 2024
2024-12-31
$45.1M-$11.5M-$8.4M$191.5M$51.5M$152.6M10-K 2026-03-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-11-06
Latest annual report10-K2026-03-11
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-21

Source: SEC EDGAR submissions feed, 181 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-7.7%
1 month+11.3%
3 months+11.8%
Year to date+28.5%
1 year+17.4%
From 52-week high-29.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
GRALGRAIL Inc. Common Stock$105.60-8.88%$4.7B
CONConcentra Group Holdings Parent Inc.$43.44+2.09%$5.5B
CDNACareDx Inc.$73.72-5.34%$3.9B
ACHCAcadia Healthcare Company Inc.$38.70+2.44%$3.6B
CAICaris Life Sciences Inc.$21.00-8.85%$6.0B
RDNTRadNet Inc.$76.89+0.61%$6.1B
CELCCelcuity Inc.$60.57-5.90%$3.0B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier